soul trial oral semaglutide cardiovascular outcomes nejm 2025 results Canadian Perspectives Whiteboard on the The SOUL Study - by

Final Thoughts BPC-157 peptide therapy continues gaining attention in wellness and recovery-focused care, but patients should understand that peptide therapy is not risk-free

The end of shortage poses meaningful concerns for public health

6M Happy Customers 9.65M Products Sold 5.2M Transformations 7.7L+ Expert Consultations 6M Happy Customers 9.65M Products Sold 5.2M Transformations 7.7L+ Expert Consultations 6M Happy Customers 9.65M Products Sold 5.2M Transformations 7.7L+ Expert Consultations

Both peptides trigger this release through the growth hormone secretagogue receptor (GHS-R) not the normal growth hormone-releasing hormone (GHRH) pathway

Preparation matters too